Long-term efficacy of combination therapy with PEG-IFN and entecavir on HBsAg loss and anti-HBs seroconversion in patients with chronic active hepatitis

Basit Öğe Kaydı
dc.authoridHarputluoglu, Muhsin Murat Muhip/0000-0002-9415-147X
dc.authoridbilgic, yılmaz/0000-0002-2169-5548
dc.authorwosidHarputluoglu, Muhsin Murat Muhip/ABI-3094-2020
dc.authorwosidSeckin, Yuksel/ABI-3468-2020
dc.authorwosidbilgic, yılmaz/ABI-6432-2020
dc.contributor.authorAladag, Murat
dc.contributor.authorAladag, Hulya
dc.contributor.authorHarputluoglu, Murat
dc.contributor.authorSeckin, Yuksel
dc.contributor.authorBilgic, Yilmaz
dc.contributor.authorKarincaoglu, Melih
dc.date.accessioned2024-08-04T20:59:54Z
dc.date.available2024-08-04T20:59:54Z
dc.date.issued2012
dc.departmentİnönü Üniversitesien_US
dc.description63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) -- NOV 09-13, 2012 -- Boston, MAen_US
dc.description.abstract[Abstract Not Available]en_US
dc.description.sponsorshipAmer Assoc Study Liver Disen_US
dc.identifier.endpage531Aen_US
dc.identifier.issn0270-9139
dc.identifier.startpage531Aen_US
dc.identifier.urihttps://hdl.handle.net/11616/103624
dc.identifier.volume56en_US
dc.identifier.wosWOS:000310955602087en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherWiley-Blackwellen_US
dc.relation.ispartofHepatologyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[No Keywords]en_US
dc.titleLong-term efficacy of combination therapy with PEG-IFN and entecavir on HBsAg loss and anti-HBs seroconversion in patients with chronic active hepatitisen_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu